Chemoinformaics analysis of (Z,Z)-?-farnesene
Molecular Weight | 190.33 | nRot | 6 |
Heavy Atom Molecular Weight | 168.154 | nRig | 4 |
Exact Molecular Weight | 190.172 | nRing | 0 |
Solubility: LogS | -5.06 | nHRing | 0 |
Solubility: LogP | 5.622 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 38.0494 |
nHD | 0 | BPOL | 22.0706 |
QED | 0.32 |
Synth | 3.239 |
Natural Product Likeliness | 2.947 |
NR-PPAR-gamma | 0.103 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.018 |
Pgp-sub | 0.006 |
HIA | 0.006 |
CACO-2 | -4.471 |
MDCK | 0.0000157 |
BBB | 0.376 |
PPB | 0.943988 |
VDSS | 5.44 |
FU | 0.0494549 |
CYP1A2-inh | 0.904 |
CYP1A2-sub | 0.374 |
CYP2c19-inh | 0.434 |
CYP2c19-sub | 0.825 |
CYP2c9-inh | 0.191 |
CYP2c9-sub | 0.917 |
CYP2d6-inh | 0.289 |
CYP2d6-sub | 0.839 |
CYP3a4-inh | 0.354 |
CYP3a4-sub | 0.235 |
CL | 14.382 |
T12 | 0.431 |
hERG | 0.012 |
Ames | 0.006 |
ROA | 0.016 |
SkinSen | 0.972 |
Carcinogencity | 0.786 |
EI | 0.986 |
Respiratory | 0.636 |
NR-Aromatase | 0.019 |
Antiviral | Yes |
Prediction | 0.720096 |